Repurposed Drugs and Nutraceutical Supplements as Neglected Complements to Cancer Treatment

Journal Title: Open Access Journal of Oncology and Medicine - Year 2018, Vol 1, Issue 5

Abstract

In ovarian cancer there is formation of tumor cells in ovarian tissues. Lysophosphatidic acid (LPA) motivated cell proliferation, migration and endurance by acting on its cognate G-protein-coupled receptors. Lysophosphatidic acid (LPA), present in ascitic fluid, motivates the enlargement of malignant ovarian tumors by raising the appearance of vascular endothelial growth factor (VEGF) in ovarian cancer cells. Ovarian cancer cell progress is repressed by alendronate, a nitrogen containing biophosphate which attenuate the establishment of Rho by blocking the mevalonate pathway. Cancer is still one of the major problems found in medical practice and in spite of clear advances in diagnosis and treatment, it remains an important cause of suffering and death in human and veterinary pathology. So there is a need to search for new approaches and ideas in this field. As of January 1, 2014, there were 14.5 million estimated survivors of the 10 most prevalent cancer sites among males and females in the United States [1]. One in four Americans will die of cancer [2] in the next years. Prevention, early diagnosis, surgery, radiotherapy, chemotherapy, immunotherapy and targeted drugs have made substantial contributions, and will continue to do so in the foreseeable future. But there is more that can be done. Since cancer is a very complex disease, it is reasonable to think that future solutions can only emerge from very sophisticated and expensive research. However, we dare to suggest that, right now, there are simple approaches that may be quite useful as complementary treatments in the management of cancer, just by re-positioning or repurposing, already approved existing drugs.

Authors and Affiliations

Tomas Koltai

Keywords

Related Articles

Acute Erythroblastic Leukemia Revealed by Dermatological Manifestations

Acute erythroblastic leukemia is characterized by the proliferation of a predominant erythrocyte population on other lineages. Cutaneous manifestations remain rare and misleading, making the diagnosis of difficult to sus...

Repurposed Drugs and Nutraceutical Supplements as Neglected Complements to Cancer Treatment

In ovarian cancer there is formation of tumor cells in ovarian tissues. Lysophosphatidic acid (LPA) motivated cell proliferation, migration and endurance by acting on its cognate G-protein-coupled receptors. Lysophosphat...

The Potential Role of Thioctic Acid in the Attenuation of Doxorubicin Induced-Cardiotoxicity

During 1950s in Italy a soil sample was isolated and found new strains of Streptomyces peucetius bacteria from which a new antibiotic was extracted with potent effect against murine tumors, this antibiotic named daunorub...

Impact of Climate Change in Indian Agriculture: Special Emphasis to Soybean (Glycine Max (L.) Merr.)

The impact of climate change on agriculture will be one of the major deciding factors influencing the future food security of mankind on earth. Agriculture is not only sensitive to climate change but, at the same time, i...

Colorectal Cancer in UAE, Implications on the Screening Program 2018

a) Colorectal cancer is the fourth (4th) common cancer in both sexes, worldwide and is the third most common cancer in men and the second in women. b) In 2012, 1.36 million cases of colorectal cancer occurred and there w...

Download PDF file
  • EP ID EP587879
  • DOI 10.32474/OAJOM.2018.01.000123
  • Views 57
  • Downloads 0

How To Cite

Tomas Koltai (2018). Repurposed Drugs and Nutraceutical Supplements as Neglected Complements to Cancer Treatment. Open Access Journal of Oncology and Medicine, 1(5), 94-96. https://europub.co.uk/articles/-A-587879